title: LABA monotherapy in asthma: an avoidable problem.
authors.affiliation: Clinical Academic Fellow, Division of Population Health Sciences, Medical Research Institute, University of Dundee, Dundee.
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Morales
mesh_terms: D000280:Administration, Inhalation; D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003692:Delayed-Action Preparations; D004351:Drug Resistance; D004359:Drug Therapy, Combination / Q000295:instrumentation; D005544:Forecasting; D006801:Humans; D055118:Medication Adherence; D009330:Nebulizers and Vaporizers; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D000068299:Salmeterol Xinafoate
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations; D000068299:Salmeterol Xinafoate; D000420:Albuterol